Patient Performance and Acceptance of Virtual Reality Visual Field Devices

University of Miami58 enrolled

Overview

The purpose of this research is to study the effectiveness and patient experience when measuring visual fields using virtual reality goggles.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Visual Field Defect, Peripheral Visual Field Defect, Nasal Step Visual Field Defect, Paracentral Scotoma of Both Eyes

Interventions

VIrtual Reality Visual Field ExamOTHER

Virtual reality visual field exam will be administered using the virtual reality headset. Exams can take up to 20 minutes.

Eligibility

Sex: ALLMin age: 13 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Any patient \>13 years old at Bascom Palmer Eye Institute * Patients who either have glaucoma, are glaucoma suspects, or have a strong family history of glaucoma Exclusion Criteria: * Adults unable to consent, pregnant women, prisoners * Patients under the age of 13

Locations (1)

Bascom Palmer Eye Institute

Miami, Florida, United States

Outcomes

Primary Outcomes

Operational Effectiveness

Operational effectiveness will be reported as the length of the visit and virtual reality visual field exam testing times. Both will be measured in minutes.

Time frame: Day 1

Medical Effectiveness as Measured by Visual Field Indexes

Medical effectiveness will be evaluated by visual field indexes, such as mean deviation, pattern standard deviation, and foveal threshold, which are all measured in decibels. These values are generated based on the participants' performance in the visual field exam.

Time frame: Day 1

Medical Effectiveness as Measured by Glaucoma Hemifield Test

Medical effectiveness will be evaluated by the glaucoma hemifield test. This value is generated based on the participants' performance in the visual field exam.

Time frame: Day 1

Reliability Indices

Reliability index is generated based on the participants' performance in the visual field exam.

Time frame: Day 1

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.